Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine-fentanyl pharmacodynamic interaction study
NL-OMON46809Completed
- Sponsor
- Indivior
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of buprenorphine and fentanyl in opioid use disorder (OUD) (4 arms), sponsored by Indivior. Primary endpoints: Peak ventilatory depression, Respiratory rate and 4 more. Started Mar 2018; status: completed.
02
Drugs
buprenorphinefentanyl
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NL-OMON46809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46809.